Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Surgery represents a fundamental component of treatment strategies in neuroendocrine neoplasms. Resection of the primary tumour, as well as locoregional and distant deposits, is currently the only modality possessing a chance of cure from neuroendocrine neoplasia disease. However, surgical intervention may also have legitimate palliative intents, such as cytoreduction of hormonally active tumour bulk that is not responsive to medical therapy and/or causes local symptoms. In some scenarios, such as in appendiceal neuroendocrine neoplasms, the adequate extent of surgery is debated. Increasingly, in advanced tumour stages, multimodal treatment approaches combining surgery with systemic targeted or liver-directed therapies to attain long-term control of disseminated disease are gaining rising attention.

Original publication




Journal article


Current Opinion in Endocrine and Metabolic Research

Publication Date





69 - 75